In last trading session, Cns Pharmaceuticals Inc (NASDAQ:CNSP) saw 0.34 million shares changing hands with its beta currently measuring 0.76. Company’s recent per share price level of $3.12 trading at $0.41 or 15.13% at ring of the bell on the day assigns it a market valuation of $8.55M. That closing price of CNSP’s stock is at a discount of -35156.41% from its 52-week high price of $1100.00 and is indicating a premium of 35.9% from its 52-week low price of $2.00. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.18 million shares which gives us an average trading volume of 629.98K if we extend that period to 3-months.
Cns Pharmaceuticals Inc (NASDAQ:CNSP) trade information
Upright in the green during last session for gaining 15.13%, in the last five days CNSP remained trading in the green while hitting it’s week-highest on Friday, 03/14/25 when the stock touched $3.12 price level, adding 6.87% to its value on the day. Cns Pharmaceuticals Inc’s shares saw a change of -48.17% in year-to-date performance and have moved 17.74% in past 5-day. Cns Pharmaceuticals Inc (NASDAQ:CNSP) showed a performance of -39.88% in past 30-days. Number of shares sold short was 0.27 million shares which calculate 0.28 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 0.5 to the stock, which implies a fall of -524.0% to its current value. Analysts have been projecting 0.5 as a low price target for the stock while placing it at a high target of 0.5. It follows that stock’s current price would jump 83.97% in reaching the projected high whereas dropping to the targeted low would mean a gain of 83.97% for stock’s current value.
Cns Pharmaceuticals Inc (CNSP) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 17.98% during past 5 years.
Cns Pharmaceuticals Inc (NASDAQ:CNSP)’s Major holders
Insiders are in possession of 0.44% of company’s total shares while institution are holding 2.58 percent of that, with stock having share float percentage of 2.59%. Investors also watch the number of corporate investors in a company very closely, which is 2.58% institutions for Cns Pharmaceuticals Inc that are currently holding shares of the company.
On the other hand, Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 6.87 shares of worth $21446.0 or 0.01% of the total outstanding shares. The later fund manager was in possession of 759.0 shares on Dec 31, 2024 , making its stake of worth around $2368.0 in the company or a holder of 0.00% of company’s stock.
